Neurogene Inc.
NGNE
$19.98
-$0.01-0.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 9.04% | 15.72% | |||
| Gross Profit | -9.04% | -15.72% | |||
| SG&A Expenses | -17.70% | 32.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.63% | 20.49% | |||
| Operating Income | -0.63% | -20.49% | |||
| Income Before Tax | 2.79% | -16.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.79% | -16.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.79% | -16.06% | |||
| EBIT | -0.63% | -20.49% | |||
| EBITDA | -0.62% | -21.45% | |||
| EPS Basic | 3.06% | -7.61% | |||
| Normalized Basic EPS | 3.06% | -7.61% | |||
| EPS Diluted | 3.06% | -7.38% | |||
| Normalized Diluted EPS | 3.06% | -7.61% | |||
| Average Basic Shares Outstanding | 0.28% | 7.84% | |||
| Average Diluted Shares Outstanding | 0.28% | 7.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||